Skip to main content
Top
Published in: Journal of Clinical Monitoring and Computing 1/2015

01-02-2015 | Commentary

4Ts scoring with hemofiltration or hemodialysis clotting

Author: Theodore E. Warkentin

Published in: Journal of Clinical Monitoring and Computing | Issue 1/2015

Login to get access

Excerpt

In this issue of Journal of Clinical Monitoring and Computing, Perbet et al. [1] report 2 intensive care unit (ICU) patients with hemofiltration filter clotting associated with heparin-induced thrombocytopenia (HIT), an immune-mediated prothrombotic adverse drug reaction [2, 3]. In both patients, early (within 6 h) hemofilter thrombosis occurred at a time when the patients were not thrombocytopenic. The authors propose that hemofilter clotting should be considered a thrombotic event in the 4Ts scoring system (discussed subsequently), even in the absence of thrombocytopenia. The authors specifically suggest [1] that rapid hemofiltration clotting should score as 2 points for the category, Thrombosis, in this scoring system. …
Literature
1.
go back to reference Perbet S, Goet T, Lebreton A, Sapin AF, Constantin JM. Repeated early hemofiltration filters clotting and heparin-induced thrombocytopenia in ICU. J Clin Monit Comput. 2014. doi:10.1007/s10877-014-9589-z. Perbet S, Goet T, Lebreton A, Sapin AF, Constantin JM. Repeated early hemofiltration filters clotting and heparin-induced thrombocytopenia in ICU. J Clin Monit Comput. 2014. doi:10.​1007/​s10877-014-9589-z.
2.
go back to reference Warkentin TE. Drug-induced immune-mediated thrombocytopenia—from purpura to thrombosis. N Engl J Med. 2007;356(9):891–3.PubMedCrossRef Warkentin TE. Drug-induced immune-mediated thrombocytopenia—from purpura to thrombosis. N Engl J Med. 2007;356(9):891–3.PubMedCrossRef
3.
go back to reference Warkentin TE. Heparin-induced thrombocytopenia in critically ill patients. Crit Care Clin. 2011;27(4):805–23.PubMedCrossRef Warkentin TE. Heparin-induced thrombocytopenia in critically ill patients. Crit Care Clin. 2011;27(4):805–23.PubMedCrossRef
4.
go back to reference Lo GK, Juhl D, Warkentin TE, Sigouin CS, Eichler P, Greinacher A. Evaluation of pretest clinical score (4 T’s) for the diagnosis of heparin-induced thrombocytopenia in two clinical settings. J Thromb Haemost. 2006;4(4):759–65.PubMedCrossRef Lo GK, Juhl D, Warkentin TE, Sigouin CS, Eichler P, Greinacher A. Evaluation of pretest clinical score (4 T’s) for the diagnosis of heparin-induced thrombocytopenia in two clinical settings. J Thromb Haemost. 2006;4(4):759–65.PubMedCrossRef
5.
go back to reference Warkentin TE, Linkins LA. Non-necrotizing heparin-induced skin lesions and the 4T’s score. J Thromb Haemost. 2010;8(7):1483–5.PubMedCrossRef Warkentin TE, Linkins LA. Non-necrotizing heparin-induced skin lesions and the 4T’s score. J Thromb Haemost. 2010;8(7):1483–5.PubMedCrossRef
6.
go back to reference McMahon CM, Cuker A. The 4Ts test in the critically ill: timing is everything. J Crit Care. 2014;29(3):468–9.PubMedCrossRef McMahon CM, Cuker A. The 4Ts test in the critically ill: timing is everything. J Crit Care. 2014;29(3):468–9.PubMedCrossRef
7.
go back to reference Cuker A, Gimotty PA, Crowther MA, Warkentin TE. Predictive value of the 4Ts scoring system for heparin-induced thrombocytopenia: a systematic review and meta-analysis. Blood. 2012;120(20):4160–7.PubMedCentralPubMedCrossRef Cuker A, Gimotty PA, Crowther MA, Warkentin TE. Predictive value of the 4Ts scoring system for heparin-induced thrombocytopenia: a systematic review and meta-analysis. Blood. 2012;120(20):4160–7.PubMedCentralPubMedCrossRef
8.
go back to reference Crowther M, Cook D, Guyatt G, Zytaruk N, McDonald E, Williamson D, Albert M, Dodek P, Finfer S, Vallance S, Heels-Ansell D, McIntrye L, Mehta S, Lamontagne F, Muscedere J, Jacka M, Lesur O, Kutsiogiannis J, Friedrich J, Klinger JR, Qushmaq I, Burry L, Kwaja K, Sheppard JA, Warkentin TE. For the PROTECT collaborators, the Canadian Critical Care Trials Group and the Australian and New Zealand Intensive Care Society Clinical Trials Group. Heparin-induced thrombocytopenia in the critically ill: interpreting the 4Ts test in a randomized trial. J Crit Care. 2014;23(3):470.e7–15.CrossRef Crowther M, Cook D, Guyatt G, Zytaruk N, McDonald E, Williamson D, Albert M, Dodek P, Finfer S, Vallance S, Heels-Ansell D, McIntrye L, Mehta S, Lamontagne F, Muscedere J, Jacka M, Lesur O, Kutsiogiannis J, Friedrich J, Klinger JR, Qushmaq I, Burry L, Kwaja K, Sheppard JA, Warkentin TE. For the PROTECT collaborators, the Canadian Critical Care Trials Group and the Australian and New Zealand Intensive Care Society Clinical Trials Group. Heparin-induced thrombocytopenia in the critically ill: interpreting the 4Ts test in a randomized trial. J Crit Care. 2014;23(3):470.e7–15.CrossRef
9.
go back to reference Lanquetot H, Leprince T, Ragot S, Boinot C, Jayle C, Robert R, Macchi L. Antithrombin level and circuit thrombosis during hemofiltration after cardiopulmonary bypass. Intensive Care Med. 2008;34(11):2068–75.PubMedCrossRef Lanquetot H, Leprince T, Ragot S, Boinot C, Jayle C, Robert R, Macchi L. Antithrombin level and circuit thrombosis during hemofiltration after cardiopulmonary bypass. Intensive Care Med. 2008;34(11):2068–75.PubMedCrossRef
10.
go back to reference Kiser TH, MacLaren R, Fish DN, Hassell KL, Teitelbaum I. Bivalirudin versus unfractionated heparin for prevention of hemofilter occlusion during continuous renal replacement therapy. Pharmacotherapy. 2010;30(11):1117–26.PubMedCrossRef Kiser TH, MacLaren R, Fish DN, Hassell KL, Teitelbaum I. Bivalirudin versus unfractionated heparin for prevention of hemofilter occlusion during continuous renal replacement therapy. Pharmacotherapy. 2010;30(11):1117–26.PubMedCrossRef
11.
go back to reference Warkentin TE. Heparin-induced thrombocytopenia: pathogenesis and management. Br J Haematol. 2003;121(4):535–55.PubMedCrossRef Warkentin TE. Heparin-induced thrombocytopenia: pathogenesis and management. Br J Haematol. 2003;121(4):535–55.PubMedCrossRef
13.
go back to reference Warkentin TE, Roberts RS, Hirsh J, Kelton JG. An improved definition of immune heparin-induced thrombocytopenia in postoperative orthopedic patients. Arch Intern Med. 2003;163(20):2518–24.PubMedCrossRef Warkentin TE, Roberts RS, Hirsh J, Kelton JG. An improved definition of immune heparin-induced thrombocytopenia in postoperative orthopedic patients. Arch Intern Med. 2003;163(20):2518–24.PubMedCrossRef
14.
go back to reference Warkentin TE, Kelton JG. A 14-year study of heparin-induced thrombocytopenia. Am J Med. 1996;101(5):502–7.PubMedCrossRef Warkentin TE, Kelton JG. A 14-year study of heparin-induced thrombocytopenia. Am J Med. 1996;101(5):502–7.PubMedCrossRef
15.
go back to reference Tang IY, Cox DS, Patel K, Reddy BV, Nahlik L, Trevino S, Murray PT. Argatroban and renal replacement therapy in patients with heparin-induced thrombocytopenia. Ann Pharmacother. 2005;39(2):231–6.PubMedCrossRef Tang IY, Cox DS, Patel K, Reddy BV, Nahlik L, Trevino S, Murray PT. Argatroban and renal replacement therapy in patients with heparin-induced thrombocytopenia. Ann Pharmacother. 2005;39(2):231–6.PubMedCrossRef
16.
go back to reference Lasocki S, Piednoir P, Aizenberg N, Geffroy A, Benbara A, Montravers P. Anti-PF4/heparin antibodies associated with repeated hemofiltration-filter clotting: a retrospective study. Crit Care. 2008;12(3):R84.PubMedCentralPubMedCrossRef Lasocki S, Piednoir P, Aizenberg N, Geffroy A, Benbara A, Montravers P. Anti-PF4/heparin antibodies associated with repeated hemofiltration-filter clotting: a retrospective study. Crit Care. 2008;12(3):R84.PubMedCentralPubMedCrossRef
Metadata
Title
4Ts scoring with hemofiltration or hemodialysis clotting
Author
Theodore E. Warkentin
Publication date
01-02-2015
Publisher
Springer Netherlands
Published in
Journal of Clinical Monitoring and Computing / Issue 1/2015
Print ISSN: 1387-1307
Electronic ISSN: 1573-2614
DOI
https://doi.org/10.1007/s10877-014-9594-2

Other articles of this Issue 1/2015

Journal of Clinical Monitoring and Computing 1/2015 Go to the issue